Sequella, Inc.

Rockville, MD

UEI
GYU1MCQEXNL5
CAGE
3XBK3
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
9610 Medical Center Dr #200, Rockville, MD 20850, USA
Website
sequella.com
Founded
1997
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
Niaaa-08-01, sequella, INC., POP 5/1/07 - 06/30/2008 phase iithis is the revised period of performance for this sbir… HHSN267200800006C National Institute of Diabetes and Digestive and Kidney Diseases (NIH) $118,776
Definitive Contract 00281200309D281033009 National Heart Lung and Blood Institute (NIH) $939,150
Biomedical (basic) 00281200209D281023006 National Heart Lung and Blood Institute (NIH) $100,000

Grant awards

Award Agency Obligated Awarded
Clinical development of SQ109 for h. Pylori infection R21DK092620 National Institutes of Health $385,653
A kit for rapid AST of mycobacterium tuberculosis from clinical samples R21AI096248 National Institutes of Health $439,950
A new therapeutic regimen for MDR-TB R43AI094844 National Institutes of Health $565,341
Clinical development of SQ109 for MDR-TB R34AI094627 National Institutes of Health $261,175
Development of a new diamine (SQ109) for the treatment of c. Difficile infection R01AI094458 National Institutes of Health $3,706,965

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Sequella, Inc. registered in SAM.gov?

Yes. Sequella, Inc.'s SAM.gov registration is active through January 1, 2027.

What is Sequella, Inc.'s most recent federal award?

Sequella, Inc.'s most recent federal grant award is Clinical development of SQ109 for h. Pylori infection (R21DK092620), from National Institutes of Health, on July 1, 2012.

On GovTribe

See Sequella, Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login